Clinical Trial Update: Platinum Rechallenge in Patients With Platinum-sensitive mTNBC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating platinum rechallenge in patients with platinum-sensitive metastatic triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN